Skip to main content

Table 1 Cases of renal-type clear cell carcinoma of the prostate in literature

From: Renal-type clear cell carcinoma of the prostate: a diagnostic challenge

S.No.

Author (Year)[Ref]

Age (years)

Serum PSA at diagnosis

Type of specimen

Microscopy

Special stain

Immunohistochemistry

Outcome (Follow-up duration)

1.

Singh et al. (2003) [2]

73

1.5 mg/dl

TURP followed by radical cystoprostatectomy + pelvic lymph node dissection

Clear cell carcinoma similar to RCC and typical prostatic adenocarcinoma (Gleason’s score 3 + 3)

Mucicarmine staining for intracytoplasmic mucin: negative

Positive: Vimentin, EMA, LMWCK and CD10

No evidence of disease (7 months)

Negative: PSA, PSAP, S-100, HMB-45, Broad spectrum cytokeratin (AE1/AE3), CK7, CK20, HMWCK, CA-125, CEA, ER and PR

2.

Pal & Chowdhury (2007) [3]

64

2.1 ng/L

TURP

Clear cell carcinoma similar to RCC

Mucicarmine staining for intracytoplasmic mucin : negative

Positive: Pancytokeratin, Vimentin and EMA

No evidence of pelvic lymph node metastasis (12 months)

Negative: PSA, PSAP and HMWCK

3.

Permi et al. (2011) [4]

64

82 ng/ml

TURP followed by radical cystoprostatectomy + pelvic lymph node dissection

Clear cell carcinoma similar to RCC

Not done

Not done

No evidence of recurrence (12 months)

4.

Wang et al. (2015) [5]

64

10.2 ng/ml

TURP

Clear cell carcinoma similar to RCC and typical prostatic adenocarcinoma (Gleason’s score 4 + 4)

Not done

Positive: LMWCK, Vimentin, EMA, CD10, PSAP and AMACR

Death due to multiorgan failure (6 months)

Negative: HMWCK, CEA, Broad spectrum cytokeratin and PAX8

5.

Present case (2015)

72

65.2 ng/ml

Radical prostatectomy and pelvic lymphadenectomy

Clear cell carcinoma similar to RCC and typical prostatic acinar adenocarcinoma (Gleason’s score 4 + 4)

Periodic acid Schiff for intracytoplasmic droplets: Positive

Positive: Pancytokeratin, EMA, CD10, Vimentin and AMACR

Alive with controlled serum PSA levels (20 months)

Negative: HMWCK (34βE12), CK7, PSA and PAX8

  1. Ref Reference in the text, PSA prostate specific antigen, TURP Transurethral resection of prostate, RCC renal cell carcinoma, EMA epithelial membrane antigen, LMWCK low molecular weight cytokeratin, PSAP prostate specific acid phosphatase, HMWCK high molecular weight cytokeratin, CEA carcinoembryonic antigen, ER estrogen receptor, PR progesterone receptor, AMACR alpha-methylacyl-CoA racemase